Earnings Feed
Start Free
Home/Insiders/Gregory Ginger
GG
SEC Insider//CIK 0001545716

Gregory Ginger

CIK 00015457162 companiesCANTON, MA
SEC Profile

Transactions

50

Companies

2

Filings

4

CIK

0001545716

Recent Transactions

50 trades
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2025-02-10$142.54/sh−634→ 17,598.101 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2025-02-10−2,159→ 0 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2025-02-10+2,159→ 18,232.101 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2025-02-07−1,635→ 1,635 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2025-02-07+1,635→ 15,312.101 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2025-02-07−1,801→ 3,604 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2025-02-07$141.35/sh−560→ 16,073.101 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2025-02-07+1,801→ 16,633.101 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2025-02-07$141.35/sh−480→ 14,832.101 total
  • Award
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2025-02-06+11,240→ 11,240 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2024-02-16+3,197→ 14,340.716 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2024-02-16$219.08/sh−1,535→ 12,805.716 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Performance Stock Unit

    2024-02-16−3,197→ 0 total
  • Other
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2024-02-16−1,879→ 0 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2024-02-16$219.08/sh−729→ 13,583.716 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2024-02-16+1,507→ 14,312.716 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2024-02-16−1,507→ 1,879 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2024-02-09−2,158→ 2,159 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2024-02-09$240.98/sh−634→ 11,143.716 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2024-02-09+2,158→ 11,777.716 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2024-02-08−1,635→ 3,270 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2024-02-08$240.30/sh−498→ 9,619.716 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2024-02-08+1,635→ 10,117.716 total
  • Award
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2024-02-07+5,405→ 5,405 total
  • Award
    BIOGEN INC.$BIIB

    Performance Stock Unit

    2024-01-29+3,197→ 3,197 total
  • Sale
    BIOGEN INC.$BIIB

    Common Stock

    2023-04-28$300.00/sh−2,681→ 8,482.716 total
  • Other
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2023-02-17−1,590→ 3,386 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2023-02-17$278.38/sh−867→ 9,280.017 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2023-02-17−1,792→ 4,976 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2023-02-17+1,792→ 11,072.017 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2023-02-10−1,132→ 1,384 total
  • Other
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2023-02-10−1,384→ 0 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2023-02-10−2,158→ 4,317 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2023-02-10$286.30/sh−2,110→ 10,147.017 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2023-02-10$286.30/sh−548→ 12,257.017 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2023-02-10+1,132→ 12,805.017 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2023-02-10$286.30/sh−648→ 11,673.017 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2023-02-10+2,158→ 12,321.017 total
  • Award
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2023-02-08+4,905→ 4,905 total
  • Award
    BIOGEN INC.$BIIB

    Common Stock

    2023-01-25+4,452→ 10,163.017 total
  • Sale
    BIOGEN INC.$BIIB

    Common Stock

    2022-11-14$300.11/sh−5,610→ 5,711.017 total
  • Other
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2022-02-18−1,995→ 6,768 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2022-02-18−1,387→ 8,763 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2022-02-18+1,387→ 11,834.617 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2022-02-18$209.79/sh−616→ 11,218.617 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2022-02-12−793→ 1,505 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2022-02-12−879→ 4,149 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2022-02-12+879→ 11,421.617 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2022-02-12$214.59/sh−584→ 10,447.617 total
  • Other
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2022-02-12−1,633→ 2,516 total

Companies

2

Recent Filings

4

Address

C/O DUNKIN' BRANDS GROUP, INC. 130 ROYALL STREET

CANTON, MA, 02021

View on SEC.gov